to page content
to site navigation
The Foundation's primary site.
Global news, events, and resources.
The national learning program for entrepreneurs.
A new approach to developing the next generation of high-growth firms.
Access to university research and innovation.
The Kauffman Foundation's charter school serving Kansas City.
Encouraging the aspirations of young people.
The platform for business plan competitions.
College preparation and access for urban youth in Kansas City.
A guide to Kauffman Foundation and partner resources, for aspiring entrepreneurs.
News and announcements from the Foundation.
From our vice president of Entrepreneurship.
From our vice president of Advancing Innovation.
News from Global Entrepreneurship Week
News about this education program for entrepreneurs.
Tweets for the eMed Community at Entrepreneurship.org
News from the Kauffman Labs program.
From our business plan competition service.
Contribute to the community seeking to improve entrepreneurship and innovation measurement.
A look at entrepreneurship from the Kauffman Foundation's Thom Ruhe.
Tracks research and policies that are accelerating economic growth and changing the world.
Brings to light various policies and initiatives to advance innovation and drive economic growth.
A selection of our videos
Take our video and audio with you.
Explore many of our publications.
Join the discussion on our LinkedIn site.
Join us on Google's social service.
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
Some medical device sales strategies that worked in the past are not recommended now. Read more for alternatives to boost sales for medical device startups.
At the 2012 Health Innovation Summit, entrepreneurs offered advice to medical companies for designing successful new health apps and devices.
DioGenix, in Gaithersburg, Md., was founded in 2009 after CEO Larry Tiffany and his senior management team saw a clear clinical need: monitoring disease progression of multiple sclerosis (MS). Tiffany has an extensive background in biotech, as an IP attorney, and as a senior executive at small and mid-size biotech companies. Before DioGenix, he was senior vice president and general manager of genomics for another genomics research company, Gene Logic.
Understanding reimbursement issues for new medical devices and therapeutics is an important part of bringing a product to market. Read more for tips from entrepreneurs who have been through this process.
Creating a successful business model is just a first step. The real work begins when the business model is tested and adapted for the real world. Read more for tips.
A new report says healthcare spending will make up 20 percent of the U.S. economy by 2019. Read more on what kind of companies can take advantage of the growing healthcare business market.
Making medical devices to solve global health problems can be tougher yet more rewarding than building medical devices for more advanced countries. Read more about how companies can serve both markets.
Biotech companies can expect to encounter a few ethical dilemmas with clinical trials and marketing. Read about ethical issues in drug development.
At this week's Biotech 2011 conference, speakers from Teva Pharmaceutical Industries and Merck spoke about how biotech companies can survive in this tough regulatory and economic environment.
Social media helps healthcare business leaders stay in touch with peers and the industry. Read one former hospital CEO's take.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.
